Research output per year
Research output per year
- 11 results
Search results
-
2024
Assessing uptake of the core outcome set in anxiety disorder clinical trials: a cross-sectional analysis
Duncan, J., Elfar, A., Magana, K., Jones, G., Ward, S., Magee, T., Modi, J., Fitzgerald, K., Hughes, G., Ford, A. I. & Vassar, M., Aug 2024, In: Quality of Life Research. 33, 8, p. 2275-2283 9 p.Research output: Contribution to journal › Article › peer-review
-
Assessment of Rehabilitation Journal Requirements for the Use of Reporting Guidelines and Clinical Trial Registration
Paul, E., Elfar, A., Peters, C., Smith, C., Nees, D., Hughes, G. & Vassar, M., Jul 2024, In: Archives of Physical Medicine and Rehabilitation. 105, 7, p. 1330-1337 8 p.Research output: Contribution to journal › Article › peer-review
-
Exploring Affordable Solutions for Orthopedic Medications: A Comparative Study of Mark Cuban Cost Plus Drug Company (MCCPDC) and Medicare
Young, A., Jelinek, T., Smith, T., Elfar, A., Rashid, M., Duncan, J., Checketts, J. X., Anderson, M. & Vassar, M., 16 Feb 2024, p. 110.Research output: Contribution to conference › Poster › peer-review
Open Access -
Exploring Clinical Trialists Perspectives on Core Outcome Sets in Anxiety Trials: A Web-Based Survey Study
Sims, S., Varughese, N., Hall, E. H., Barks, N., Duncan, J., Elfar, A., Chaudhry, A., Cox, K., Ernst, Z., Hughes, G. & Vassar, M., 16 Feb 2024, p. 92.Research output: Contribution to conference › Poster › peer-review
Open Access -
Reducing Men's Health Drug Costs: Exploring the Impact of the Mark Cuban Cost Plus Drug Company Model on Medicare Savings
Khan, A., Kari, K., Elfar, A., Oldham, E., Duncan, J., Rashid, M. & Vassar, M., 3 Feb 2024.Research output: Contribution to conference › Poster › peer-review
File34 Downloads (Pure) -
2023
An Assessment of the Clinical Trial Portfolio of Selinexor in Solid and Non-Solid Malignancies: A Preliminary Study
Elfar, A., Tran, A. V., Case, J., Hughes, G. K., McIntire, R., Gardner, B., Ladd, C., Peña, A. M., Wayant, C., Tuia, J., Haslam, A., Prasad, V. & Vassar, M., 21 Jul 2023.Research output: Contribution to conference › Poster › peer-review
Open AccessFile23 Downloads (Pure) -
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Olaparib Clinical Trials
Case, J. M., Elfar, A., Tran, A. V., Hughes, G. K., Gardner, B., Ladd, C., Pena, A., McIntire, R., Schovanec, A., Tuia, J., Haslam, A., Prasad, V. & Vassar, M., 21 Jul 2023.Research output: Contribution to conference › Poster › peer-review
-
Evaluation of the Clinical Trial Portfolio of Olaparib
Case, J., Elfar, A., Tran, A. V., Hughes, G. K., Gardner, B., Ladd, C., Peña, A., McIntire, R., Schovanec, A., Tuia, J., Haslam, A., Prasad, V. & Vassar, M., 21 Jul 2023.Research output: Contribution to conference › Poster › peer-review
Open AccessFile27 Downloads (Pure) -
Lack of Reporting Guidelines and Clinical Trial Registration In Physical Medicine & Rehabilitation
Paul, E., Elfar, A., Peters, C., Smith, C., Hughes, G. & Vassar, M., 3 Mar 2023, p. 16.Research output: Contribution to conference › Poster › peer-review
-
Lack of Reporting Guidelines and Clinical Trial Registration In Physical Medicine & Rehabilitation
Paul, E., Elfar, A., Peters, C., Smith, C., Nees, D., Hughes, G. & Vassar, M., 17 Feb 2023, p. 88.Research output: Contribution to conference › Poster › peer-review
Open Access -
Reducing Men's Health Drug Costs: Exploring the Impact of the Mark Cuban Cost Plus Drug Company Model on Medicare Savings
Khan, A., Kari, K., Elfar, A., Oldham, E., Duncan, J., Rashid, M. & Vassar, M., 15 Sep 2023.Research output: Contribution to conference › Poster › peer-review
Open AccessFile24 Downloads (Pure)